CIK 0000315545
- Non-accelerated filer
- Smaller reporting company
PROVECTUS BIOPHARMACEUTICALS, INC.
Sign in to watch- Ticker
- PVCT
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 900031917
- Phone
- +1 866-594-5999
- Business address
- 800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
- Former names
- PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3/A Insider 3/A
- 4 Grant or award CFO acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 800,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 50,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy See Remarks bought 200,000 shares at an average $0.05 ($10,792)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition Interim CEO, CFO, COO acquired 266,666 shares (code O)
- 4 Other acquisition Chief Technology Officer acquired 306,947 shares (code O)
- 4 Other acquisition Director acquired 200,000 shares (code O)
Page 9 of 19 · 367 filings